Eosinophilia in bronchoalveolar lavage fluid and architectural destruction are features of desquamative interstitial pneumonia

Histopathology
Y KawabataThomas V Colby

Abstract

Desquamative interstitial pneumonia (DIP) is a rare pattern of diffuse parenchymal lung disease known to overlap with respiratory bronchiolitis-interstitial lung disease (RB-ILD). The aim was to review biopsy-proven cases of DIP to investigate further the clinical, imaging and histological features of this disease. Twenty patients fulfilled the pathological criteria: 19 men and one woman with a mean age of 54 years. Clinical features, bronchoalveolar lavage (BAL) data, radiological findings, pathological findings other than criteria, effect of therapy and outcome were examined. The BAL data for 17 cases revealed marked eosinophilia (mean 18%) and moderate neutrophilia (mean 11%). Computed tomography in 17 patients showed peripheral involvement in all cases with a clear margin in 64% and thin-walled cysts in 35% of cases. Additional pathological features were a distinct lobular distribution (70%) and architectural destruction (70%) with cyst formation (55%). Eighteen of the 19 patients (95%) improved under steroid pulse and/or oral therapy. Sixteen subjects (80%) are alive, three died of other diseases and one died of DIP 74 months after the diagnosis. Percent vital capacity increased significantly and new thin-walled cysts appe...Continue Reading

References

Apr 13, 1978·The New England Journal of Medicine·C B CarringtonR G Gupta
Apr 1, 1987·The American Review of Respiratory Disease·J L MyersA L Katzenstein
Jan 20, 1966·The New England Journal of Medicine·E A GaenslerC M Prowse
Jul 23, 1982·Science·D E Niewoehner, J R Hoidal
Apr 1, 1995·Tubercle and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·D A Enarson
Aug 1, 1994·The European Respiratory Journal·K YoshidaS Abe
Jun 1, 1996·The Korean Journal of Internal Medicine·C S ParkC H Kang
Jan 28, 1998·American Journal of Respiratory and Critical Care Medicine·J A BjorakerK P Offord
May 1, 1998·American Journal of Respiratory and Critical Care Medicine·A L Katzenstein, J L Myers
Sep 4, 2003·The European Respiratory Journal·S VeeraraghavanR M du Bois
Sep 1, 1965·The American Journal of Medicine·A A LIEBOWJ G BILLINGSLEY
Oct 18, 2006·Internal Medicine·Toru AraiMitsunori Sakatani

❮ Previous
Next ❯

Citations

Jul 19, 2014·Archives of Pathology & Laboratory Medicine·Andrew ChurgAnaMaria Bilawich
Jan 1, 2015·Clinical Medicine Insights. Circulatory, Respiratory and Pulmonary Medicine·Mikiko Hashisako, Junya Fukuoka
Apr 19, 2008·Internal Medicine·Takashi IshiguroYoshinori Kawabata
Jul 29, 2009·Current Opinion in Pulmonary Medicine·Herbert Y Reynolds
May 11, 2010·Internal Medicine·Hiroshi IshiiJun-ichi Kadota
Dec 31, 2015·Pediatric Pulmonology·Lisa Giovannini-ChamiJacques de Blic
Jul 19, 2012·Respirology : Official Journal of the Asian Pacific Society of Respirology·Yoshinori KawabataUNKNOWN Desquamative Interstitial Pneumonia Study Group
Dec 20, 2015·Respirology : Official Journal of the Asian Pacific Society of Respirology·Venerino PolettiSara Tomassetti
Jun 20, 2017·Internal Medicine·Hideaki YamakawaTakashi Ogura
Sep 22, 2010·Histopathology·Henry D TazelaarAndrew Churg
Aug 28, 2020·Expert Review of Respiratory Medicine·Stanca-Patricia HogeaCristian Oancea
Jun 26, 2020·European Respiratory Review : an Official Journal of the European Respiratory Society·Vincent Cottin
Mar 24, 2015·Deutsches Ärzteblatt International·Lars Hagmeyer, Winfried Randerath
Jul 31, 2019·Annals of Medicine and Surgery·Ole Weis BjerrumChristen Lykkegaard Andersen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.